Filing Flows › Skinvisible (SKVI) › Q3 2025
Skinvisible (SKVI) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 13, 2025
Skinvisible (SKVI) reported revenue of $5K for the third quarter 2025 (Q3 2025), 0% from a year earlier and 0% from the quarter before.
Skinvisible, Q3 2025: revenue $5K (0% year over year), net loss $250K, operating cash flow $1K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | 0% | 0% |
| Operating profit | −$106K | — | — |
| Net earnings | −$250K | — | — |
| Operating cash flow | $1K | — | — |
What changed
Revenue was $5K in Q3 2025, roughly flat year over year and roughly flat from the previous quarter.
Gross margin was 100.0%, unchanged from a year earlier. Operating costs exceeded revenue by $106K, an operating margin of -2121.1%. Operating expenses fell 15% while revenue was flat. The quarter ended with a net loss of $250K, narrower than the previous quarter's $274K loss. Net interest and other expense of $144K was the main reason.
Operating cash flow was $1K. Non-cash charges added back $5K of depreciation and amortization. Working capital and other items added $246K. Capital expenditures of −$0K left free cash flow of $1K.
Questions
What was Skinvisible's revenue in the third quarter 2025?
Skinvisible (SKVI) reported revenue of $5K for the third quarter 2025 (Q3 2025), 0% from a year earlier and 0% from the quarter before.
Source: Skinvisible 10-Q on SEC EDGAR.